By Richard Jefferys, with the assistance of Claire Wingfield, Eleonora Jimenez and Javid Syed. 7/1/2011 - The relatively small community of researchers, policymakers and advocates involved in the search for an effective TB vaccine met in Tallinn, Estonia in September,…
TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.
TB Alliance's REMox TB program leverages ACTG sites to advance testing of improved TB treatments November 15, 2011, Durban, South Africa— The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' (NIAID)…
Tuberculosis Research and Development: 2010 Report on Tuberculosis Research Funding trends, 2005-2009: 2nd Edition By Eleonora Jimenez March 2011 - This is the 2nd Edition of the Stop TB Partnership and Treatment Action Group’s 2010 report on funding trends for…
By Claire Wingfield It is estimated that of the nine million new cases of tuberculosis (TB) each year, one million occur among children under the age of 15. Yet advocacy for prevention, diagnosis, and treatment of TB in children has…
By Coco Jervis and Sue Perez Negligible Increases for AIDS, TB, Viral Hepatitis Treatment and Research On Monday, February 1, 2010, President Barack Obama unveiled his fiscal year (FY) 2011 budget to the U.S. Congress. Global health programs were allocated…
By Javid Syed BOTUSA study strongly supports continuous preventive IPT for people with HIV Tuberculosis (TB) remains the leading cause of death among people living with HIV. The World Health Organization’s 2009 report Global Tuberculosis Control: Epidemiology, Strategy, Financing reported…